Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1634 1683
This examiner grants 63% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 16739866 | FUNCTIONAL ANALYSIS OF CANCER CELLS | Non-Final OA | Dana-Farber Cancer Institute, Inc. |
| 19344246 | METHODS FOR THREE-DIMENSIONAL NUCLEIC ACID SEQUENCING | Non-Final OA | Singular Genomics Systems Inc. |
| 18132298 | METHODS AND COMPOSITIONS FOR LIGATION AND SAMPLE ANALYSIS | Final Rejection | 10x Genomics, Inc. |
| 17812075 | METHODS FOR SAMPLE TRANSFER FOR IN SITU ANALYSIS | Non-Final OA | 10x Genomics, Inc. |
| 18074369 | METHOD OF MAPPING SPATIAL DISTRIBUTIONS OF CELLULAR COMPONENTS | Final Rejection | CALIFORNIA INSTITUTE OF TECHNOLOGY |
| 17297859 | TARGETED ENRICHMENT BY ENDONUCLEASE PROTECTION | Final Rejection | KEYGENE N.V. |
| 17821449 | MEASUREMENT OF PROTEIN EXPRESSION USING REAGENTS WITH BARCODED OLIGONUCLEOTIDE SEQUENCES | Non-Final OA | Becton, Dickinson and Company |
| 17207040 | COMPOSITIONS AND METHODS FOR DIAGNOSING AND TREATING ARRHYTHMIAS | Non-Final OA | Arizona Board of Regents on Behalf of the University of Arizona |
| 17905724 | MAGNETIC SENSOR ARRAYS FOR NUCLEIC ACID SEQUENCING AND METHODS OF MAKING AND USING THEM | Final Rejection | Roche Sequencing Solutions, Inc. |
| 17344535 | METHODS FOR PURIFICATION OF MESSENGER RNA | Non-Final OA | Translate Bio, Inc. |
| 17917826 | RESPONSIVE, CATALYTIC NUCLEIC NANOSTRUCTURES | Final Rejection | Agency for Science, Technology and Research |
| 17636582 | COMPOSITIONS AND METHODS FOR AMPLIFICATION OF STR LOCI | Final Rejection | QIAGEN GMBH |
| 13703309 | METHOD FOR DETERMINATION OF TARGET CELLS OR TISSUE FOR EXTRACTION OF BIOMOLECULES FROM FIXED BIOLOGICAL SAMPLES | Final Rejection | QIAGEN GMBH |
| 18059370 | METHODS OF CAPTURING CELL-FREE METHYLATED DNA AND USES OF SAME | Non-Final OA | Sinai Health System |
| 17564592 | METHOD AND SYSTEM EMPLOYING DISTINGUISHABLE POLYMERASES FOR DETECTING TERNARY COMPLEXES AND IDENTIFYING COGNATE NUCLEOTIDES | Final Rejection | ILLUMNA CAMBRIDGE LIMITED |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy